Notice: This company has been marked as potentially delisted and may not be actively trading. Cerecor (CERC) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Aytu BioPharma Stock (NASDAQ:AYTU) Insider TradesDecember 19, 2023 | benzinga.commTOR Inhibitors Global Market Report 2023August 24, 2023 | uk.finance.yahoo.comDelveInsight Highlights Major Advances, Transformative Therapies, and 80+ Leading Players Wheeling the Crohn's Disease Pipeline LandscapeMay 11, 2023 | finance.yahoo.comEdited Transcript of AYTU.OQ earnings conference call or presentation 27-Sep-22 8:30pm GMT - Yahoo FinanceSeptember 28, 2022 | finance.yahoo.comAytu BioPharma, Inc. (AYTU) CEO Josh Disbrow on Q4 2022 Results - Earnings Call Transcript - Seeking AlphaSeptember 28, 2022 | seekingalpha.comDiGeorge Syndrome Drug Market In-Depth Analysis Research Report 2029August 31, 2022 | marketwatch.comValenzaBio Appoints Industry Veteran Peter Greenleaf to its Board of Directors - StreetInsider.comAugust 24, 2022 | streetinsider.comValenzaBio Appoints Industry Veteran Peter Greenleaf to its Board of Directors - Business WireAugust 24, 2022 | businesswire.comCelldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update - GlobeNewswireAugust 11, 2022 | globenewswire.comCelldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update - StreetInsider.comAugust 9, 2022 | streetinsider.comCelldex Therapeutics : Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Form 8-K - Marketscreener.comAugust 8, 2022 | marketscreener.comAvalo Therapeutics, Inc. (AVTX) Stock Price Today, Quote & News - Seeking AlphaJuly 24, 2022 | seekingalpha.comPhiladelphia biotech news: Updates from CHOP, Helius Medical, GSK and more - Philadelphia Business Journal - The Business JournalsJuly 15, 2022 | bizjournals.comThe Axial Spondyloarthritis Market is Predicted to Grow with a CAGR of 4.7% by 2032, Analyzes DelveInsight - PR NewswireMay 3, 2022 | prnewswire.comDiGeorge Syndrome Drug Market Size, Share, Industry Growth & Forecast By 2029May 1, 2022 | marketwatch.comAACR Poster Presentation: CFT7455 Phase 1/2 Cohort A - Marketscreener.comApril 8, 2022 | marketscreener.comDiGeorge Syndrome Drug Market High Demand, Size, Share, Processing Industry, And Forecast By 2029 - Benzi - BenzingaMarch 28, 2022 | benzinga.comModel N Announces Fourth Quarter and Fiscal Year 2021 Financial Results - Business WireNovember 10, 2021 | businesswire.comModel N (MODN) Q4 Earnings & Revenues Top Estimates, Up Y/Y - NasdaqNovember 10, 2021 | nasdaq.comModel N Announces Fourth Quarter and Fiscal Year 2021 Financial Results - Yahoo FinanceNovember 9, 2021 | finance.yahoo.comAvalo Reports Third Quarter 2021 Financial Results and Provides Business Updates - Yahoo FinanceNovember 9, 2021 | finance.yahoo.comModel N Announces Fourth Quarter and Fiscal Year 2021 Financial Results - StockhouseNovember 9, 2021 | stockhouse.comHorizon Technology Finance Provides Third Quarter 2021 Portfolio Update - Yahoo FinanceOctober 7, 2021 | finance.yahoo.comInovio's experimental Covid-19 vaccine takes another step, plus other life sciences news - Philadelphia Business Journal - Philadelphia Business JournalAugust 27, 2021 | bizjournals.comCERECOR : Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc (Form 8-K) - Marketscreener.comAugust 27, 2021 | marketscreener.comAvalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc. - Yahoo FinanceAugust 27, 2021 | yahoo.comAvalo Therapeutics, Inc. Announces Corporate Name Change - GlobeNewswireAugust 26, 2021 | globenewswire.comCerecor changes name to Avalo Therapeutics with new Nasdaq ticker - Seeking AlphaAugust 26, 2021 | seekingalpha.comAvalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc.August 26, 2021 | finance.yahoo.comCerecor Reports Second Quarter 2021 Financial Results and Provides Business Updates - Yahoo FinanceAugust 2, 2021 | finance.yahoo.comCerecor Reports Second Quarter 2021 Financial Results and - GlobeNewswireAugust 2, 2021 | globenewswire.comCerecor Reports Second Quarter 2021 Financial Results and Provides Business UpdatesAugust 2, 2021 | finance.yahoo.comCerecor Announces Drawdown of $10 Million Tranche under its - GlobeNewswireAugust 2, 2021 | globenewswire.com44 Stocks Moving In Tuesday's Mid-Day Session - Markets InsiderJuly 28, 2021 | markets.businessinsider.comCerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease - GlobeNewswireJuly 27, 2021 | globenewswire.comAfter-Hours Stock Movers 07/26: (CERC) (UHS) (FFIV) Higher; (BTBT) (MINM) (TDUP) Lower (more...) - StreetInsider.comJuly 27, 2021 | streetinsider.comCerecor's Crohn's Disease Candidate Shows Encouraging Response In Pretreated PatientsJuly 27, 2021 | finance.yahoo.comCerecor Announced Initial Phase 1b Results For CERC-002 In Moderate To Severe Crohn's Disease Patients - BenzingaJuly 26, 2021 | benzinga.comCERECOR INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K) - marketscreener.comJuly 26, 2021 | marketscreener.comCerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease Patients - Yahoo FinanceJuly 26, 2021 | finance.yahoo.com Get Cerecor News Delivered to You Automatically Sign up to receive the latest news and ratings for CERC and its competitors with MarketBeat's FREE daily newsletter. Email Address CERC Media Mentions By Week CERC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CERC News Sentiment▼0.160.60▲Average Medical News Sentiment CERC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CERC Articles This Week▼00▲CERC Articles Average Week Get Cerecor News Delivered to You Automatically Sign up to receive the latest news and ratings for CERC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Catalyst Pharmaceuticals News MoonLake Immunotherapeutics News Merus News Arrowhead Pharmaceuticals News HUTCHMED News Edgewise Therapeutics News Mirum Pharmaceuticals News Amneal Pharmaceuticals News Gemini Therapeutics News Protagonist Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CERC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerecor Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerecor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
